Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (171-180 of 284) with videos related to

Pageof 29
Sort By:
Blood|December 12, 2001
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studiesG Socié, R A Clift, D Blaise, et al.
Experimental Hematology|April 13, 2001
Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cellsH Tayebi, F Kuttler, P Saas, et al.
British Journal of Haematology|February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?O Ringdén, M Labopin, N C Gorin, et al.
Leukemia|June 27, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparisonM Mohty, H de Lavallade, J El-Cheikh, et al.
Leukemia|September 20, 2014
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working PartyA Tanase, N Schmitz, H Stein, et al.
Leukemia|June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)A Pigneux, M Labopin, J Maertens, et al.
Bone Marrow Transplantation|April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMTT Czerw, M Labopin, N-C Gorin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomasK Bouabdallah, S Furst, J Asselineau, et al.
Blood|November 5, 1997
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Ferrant, M Labopin, F Frassoni, et al.
Hematology and Cell Therapy|April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvementF Viret, D Blaise, R Bouabdallah, et al.
Pageof 29

Showing results (171-180 of 284) with videos related to

Sort By:
Pageof 29
Blood|December 12, 2001
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studiesG Socié, R A Clift, D Blaise, et al.
Experimental Hematology|April 13, 2001
Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cellsH Tayebi, F Kuttler, P Saas, et al.
British Journal of Haematology|February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?O Ringdén, M Labopin, N C Gorin, et al.
Leukemia|June 27, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparisonM Mohty, H de Lavallade, J El-Cheikh, et al.
Leukemia|September 20, 2014
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working PartyA Tanase, N Schmitz, H Stein, et al.
Leukemia|June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)A Pigneux, M Labopin, J Maertens, et al.
Bone Marrow Transplantation|April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMTT Czerw, M Labopin, N-C Gorin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomasK Bouabdallah, S Furst, J Asselineau, et al.
Blood|November 5, 1997
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Ferrant, M Labopin, F Frassoni, et al.
Hematology and Cell Therapy|April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvementF Viret, D Blaise, R Bouabdallah, et al.
Pageof 29